Sex-Specific Cardiovascular Risk of Lower Potassium Intake in Patients with CKD

Tatsuya Suenaga1, Shigeru Tanaka1, Hiromasa Kitamura1

  • 1Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Insights

Low potassium intake increases cardiovascular disease (CVD) risk in chronic kidney disease (CKD) patients. This risk is significantly higher in women, highlighting the importance of sex-specific considerations for dietary potassium in CKD management.

Area of Science:

  • Nephrology
  • Cardiology
  • Nutritional Science

Background:

  • Lower potassium intake is linked to increased cardiovascular disease (CVD) risk in the general population.
  • Sex differences in this association are noted, but poorly understood in chronic kidney disease (CKD) patients.
  • Limited research exists on potassium intake and CVD risk specifically within the CKD population, especially regarding sex-specific effects.

Purpose of the Study:

  • To investigate the association between estimated dietary potassium intake and the risk of CVD events in patients with CKD.
  • To examine potential sex-specific differences in the relationship between potassium intake and CVD risk among CKD patients.

Main Methods:

  • Prospective follow-up of 4,314 adult CKD patients in Japan over 5 years.
  • Estimated potassium intake calculated using the Tanaka formula from spot urine samples, categorized into sex-specific quartiles.
  • Cox proportional hazards models used to assess CVD risk, with analyses stratified by sex.

Main Results:

  • A total of 431 CVD events occurred during the 5-year follow-up.
  • Overall, the lowest quartile of potassium intake showed a trend towards higher CVD risk (HR 1.41 [0.97-2.03]).
  • A significant interaction between sex and potassium intake was observed (p<0.001), with lower potassium intake significantly increasing CVD risk in women (HR 2.97 [1.44-6.10]) but not in men (HR 0.98 [0.63-1.53]).

Conclusions:

  • Lower estimated potassium intake is associated with an elevated risk of CVD in patients with CKD.
  • This association is particularly pronounced in women, suggesting a critical sex-specific difference in dietary potassium's role in CVD risk for this population.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
662
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.7K
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
669
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.3K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.2K